Influence of the sample matrix on the stability of beta-CTX at room temperature for 24 and 48 hours.
Lippi G, Brocco G, Salvagno GL, Montagnana M, Guidi GC, Schmidt-Gayk H
Purpose
Conclusion
Studies (1)
Purpose
The purpose of this study was to determine the effects of anticoagulant type, measurement in serum instead of plasma and storage at room temperature on levels of B-CTX. Three blood specimens were collected, without venous stasis, from 23 fasting patients, centrifuged at 1500 g within 2 h, and aliquots of the plasma and serum were stored at room temperature.
Summary of Findings
K2 EDTA-plasma and serum had significantly more B-CTX than lithium heparin-plasma (0.47 and 0.48 ng/ml, respectively versus 0.44 ng/mL, p<0.001, both). When lithium heparin-plasma, K2 EDTA-plasma and serum were stored at room temperature for 24 h, B-CTX levels decreased from initial levels by 29.1%, 4.4% and 17.6%, respectively. When lithium heparin-plasma, K2 EDTA-plasma and serum were stored at room temperature for 48 h, B-CTX levels further decreased from baseline by 44.4%, 5.1% and 28.6%, respectively. The decreases in B-CTX levels after storage of lithium heparin-plasma and serum exceeded the 20% mean biological variation and showed a high degree of inter-individual variability.
Biospecimens
FluidPlasmaFluidSerumFluidBloodPreservation Types
None (Fresh)Diagnoses
Not specifiedPlatforms
PeptideClinical chemistry/auto analyzerPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Biospecimen Acquisition Anticoagulant Lithium heparinNonePotassium EDTABiospecimen Aliquots and Components Blood and blood products PlasmaSerumStorage Time at room temperature 0 h24 h48 h